Scaffolds for growth factor delivery as applied to bone tissue engineering

International Journal of Polymer Science

Volumn 2012, Issue , 2012, Pages

  Blackwood, Keith A ^a   Bock, Nathalie ^a   Dargaville, Tim R ^a   Ann Woodruff, Maria ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; COST ENGINEERING; TISSUE; TISSUE REGENERATION;

AUTOLOGOUS BONE GRAFTING; BONE REGENERATION; BONE TISSUE ENGINEERING; DESIGN CONSIDERATIONS; GROWTH FACTOR DELIVERY; POLYMERIC SCAFFOLD; STRUCTURAL FEATURE; TISSUE-ENGINEERED SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

EID: 84873848899     PISSN: 16879422     EISSN: 16879430     Source Type: Journal    
DOI: 10.1155/2012/174942     Document Type: Review

References (165)

1. Burge R., Dawson-Hughes B., Solomon D. H., Wong J. B., King A., Tosteson A., Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. Journal of Bone and Mineral Research 2007 22 3 465 475 2-s2.0-34247194211 10.1359/jbmr.061113 (Pubitemid 46797130)
2. Sanders K. M., Nicholson G. C., Ugoni A. M., Pasco J. A., Seeman E., Kotowicz M. A., Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Medical Journal of Australia 1999 170 10 467 470 2-s2.0-0033577741 (Pubitemid 29224964)
3. Ferrara N., Gerber H. P., LeCouter J., The biology of VEGF and its receptors. Nature Medicine 2003 9 6 669 676 2-s2.0-0037699954 10.1038/nm0603-669 (Pubitemid 36749215)
4. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J. M., Fujisawa-Sehara A., Suda T., Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. The Journal of Cell Biology 1994 127 6 1755 1766 2-s2.0-0027946689 10.1083/jcb.127.6.1755 (Pubitemid 24380911)
5. Inada M., Katagiri T., Akiyama S., Namiki M., Komaki M., Yamaguchi A., Kamoi K., Rosen V., Suda T., Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochemical and Biophysical Research Communications 1996 222 2 317 322 2-s2.0-0030585355 10.1006/bbrc.1996.0742 (Pubitemid 26335014)
6. Kirker-Head C. A., Potential applications and delivery strategies for bone morphogenetic proteins. Advanced Drug Delivery Reviews 2000 43 1 65 92 2-s2.0-0034666480 10.1016/S0169-409X(00)00078-8
7. Deckers M. M. L., van Bezooijen R. L., van der Horst G., Hoogendam J., Van Chris Bent D. E. R., Papapoulos S. E., Löwik C. W. G. M., Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002 143 4 1545 1553 2-s2.0-0036217067 10.1210/en.143.4.1545 (Pubitemid 34274386)
8. Fiedler J., Röderer G., Günther K. P., Brenner R. E., BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. Journal of Cellular Biochemistry 2002 87 3 305 312 2-s2.0-0036035005 10.1002/jcb.10309 (Pubitemid 35231716)
9. Friess W., Uludag H., Foskett S., Biron R., Sargeant C., Characterization of absorbable collagen sponges as rhBMP-2 carriers. International Journal of Pharmaceutics 1999 187 1 91 99 2-s2.0-0032879991 10.1016/S0378-5173(99)00174-X (Pubitemid 29435976)
10. Hollinger J. O., Schmitt J. M., Buck D. C., Shannon R., Joh S. P., Zegzula H. D., Wozney J., Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. Journal of Biomedical Materials Research 1998 43 4 356 364 (Pubitemid 28544095)
11. Carragee E. J., Hurwitz E. L., Weiner B. K., A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine Journal 2011 11 6 471 491 2-s2.0-79959950769 10.1016/j.spinee.2011.04.023
12. Vasita R., Katti D. S., Growth factor-delivery systems for tissue engineering: a materials perspective. Expert Review of Medical Devices 2006 3 1 29 47 2-s2.0-33644840292 10.1586/17434440.3.1.29
13. Chen R. R., Mooney D. J., Polymeric growth factor delivery strategies for tissue engineering. Pharmaceutical Research 2003 20 8 1103 1112 2-s2.0-0042626603 10.1023/A:1025034925152 (Pubitemid 36951832)
14. Porter J. R., Ruckh T. T., Popat K. C., Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnology Progress 2009 25 6 1539 1560 2-s2.0-73249127019 10.1002/btpr.246
15. Noda M., Cellular and Molecular Biology of Bone 1993 New York, NY, USA Academic Press
16. Reichert J. C., Saifzadeh S., Wullschleger M. E., Epari D. R., Schütz M. A., Duda G. N., Schell H., van Griensven M., Redl H., Hutmacher D. W., The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009 30 12 2149 2163 2-s2.0-60849106318 10.1016/j.biomaterials.2008.12.050
17. Szpalski C., Barr J., Wetterau M., Saadeh P. B., Warren S. M., Cranial bone defects: current and future strategies. Neurosurgical Focus 2010 29 6 E8 2-s2.0-79952118385
18. Vaccaro A. R., Singh K., Haid R., Kitchel S., Wuisman P., Taylor W., Branch C., Garfin S., The use of bioabsorbable implants in the spine. Spine Journal 2003 3 3 227 237 2-s2.0-0642310747 10.1016/S1529-9430(02)00412-6 (Pubitemid 38351753)
19. Soucacos P. N., Johnson E. O., Babis G., An update on recent advances in bone regeneration. Injury 2008 39 supplement 2 S1 S4 2-s2.0-51649090131 10.1016/S0020-1383(08)70009-3
20. Younger E. M., Chapman M. W., Morbidity at bone graft donor sites. Journal of orthopaedic trauma 1989 3 3 192 195 2-s2.0-0024377022
21. Dimitriou R., Mataliotakis G. I., Angoules A. G., Kanakaris N. K., Giannoudis P. V., Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury 2011 42 supplement 2 S3 S15 2-s2.0-79959411111 10.1016/j.injury.2011.06.015
22. Rogers B. A., Sternheim A., Backstein D., Safir O., Gross A. E., Proximal femoral allograft for major segmental femoral bone loss: a systematic literature review. Advances in Orthopedics 2011 2011 7 257572
23. Woodruff M. A., Hutmacher D. W., The return of a forgotten polymer-polycaprolactone in the 21st century. Progress in Polymer Science 2010 35 10 1217 1256 2-s2.0-77957588918 10.1016/j.progpolymsci.2010.04.002
24. Geiger M., Li R. H., Friess W., Collagen sponges for bone regeneration with rhBMP-2. Advanced Drug Delivery Reviews 2003 55 12 1613 1629 2-s2.0-0242659880 10.1016/j.addr.2003.08.010 (Pubitemid 37420006)
25. Kolambkar Y. M., Dupont K. M., Boerckel J. D., Huebsch N., Mooney D. J., Hutmacher D. W., Guldberg R. E., An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 2011 32 1 65 74 2-s2.0-78349309536 10.1016/j.biomaterials.2010.08.074
26. Gu Y., Chen L., Yang H. L., Luo Z. P., Tang T. S., Evaluation of an injectable silk fibroin enhanced calcium phosphate cement loaded with human recombinant bone morphogenetic protein-2 in ovine lumbar interbody fusion. Journal of Biomedical Materials Research A 2011 97 2 177 185 2-s2.0-79953066984 10.1002/jbm.a.33018
27. Place E. S., Evans N. D., Stevens M. M., Complexity in biomaterials for tissue engineering. Nature Materials 2009 8 6 457 470 2-s2.0-66249146049 10.1038/nmat2441
28. Vert M., Li S. M., Spenlehauer G., Guerin P., Bioresorbability and biocompatibility of aliphatic polyesters. Journal of Materials Science 1992 3 6 432 446 2-s2.0-5544292026 10.1007/BF00701240
29. Daniels A. U., Chang M. K., Andriano K. P., Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone. Journal of Applied Biomaterials 1990 1 1 57 78 2-s2.0-0025389116
30. Kulkarni R. K., Pani K. C., Neuman C., Leonard F., Polylactic acid for surgical implants. Archives of Surgery 1966 93 5 839 843 2-s2.0-0013965320
31. Paeng J. Y., Hong J., Kim C. S., Kim M. J., Comparative study of skeletal stability between bicortical resorbable and titanium screw fixation after sagittal split ramus osteotomy for mandibular prognathism. Journal of Cranio-Maxillofacial Surgery. In press 10.1016/j.jcms.2011.11.001
32. Holmes R. E., Cohen S. R., Cornwall G. B., Thomas K. A., Kleinhenz K. K., Beckett M. Z., MacroPore resorbable devices in craniofacial surgery. Clinics in Plastic Surgery 2004 31 3 393 406 2-s2.0-3042552463 10.1016/j.cps.2004.03.003 (Pubitemid 38829237)
33. Ashammakhi N., Rokkanen P., Absorbable polyglycolide devices in trauma and bone surgery. Biomaterials 1997 18 1 3 9 2-s2.0-0031016140 10.1016/S0142-9612(96)00107-X (Pubitemid 27029708)
34. Kim B. C., Padwa B. L., Park H. S., Jung Y. S., Stability of maxillary position after le fort i osteotomy using self-reinforced biodegradable poly-70L/30DL-lactide miniplates and screws. Journal of Oral and Maxillofacial Surgery 2011 69 5 1442 1446 2-s2.0-79955035691 10.1016/j.joms.2010.05.033
35. Kamitakahara M., Ohtsuki C., Miyazaki T., Behavior of ceramic biomaterials derived from tricalcium phosphate in physiological condition. Journal of Biomaterials Applications 2008 23 3 197 212 2-s2.0-55349129981 10.1177/0885328208096798
36. Place E. S., Rojo L., Gentleman E., Sardinha J. P., Stevens M. M., Strontium-and zinc-alginate hydrogels for bone tissue engineering. Tissue Engineering A 2011 17 21-22 2713 2722 2-s2.0-80155149836 10.1089/ten.tea.2011. 0059
37. Haidar Z. S., Hamdy R. C., Tabrizian M., Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnology Letters 2009 31 12 1825 1835 2-s2.0-73949143647 10.1007/s10529-009-0100-8
38. Williams D., Revisiting the definition of biocompatibility. Medical Device Technology 2003 14 8 10 13 2-s2.0-0642365217
39. Chen D., Zhao M., Mundy G. R., Bone morphogenetic proteins. Growth Factors 2004 22 4 233 241 2-s2.0-12344291865 10.1080/08977190412331279890 (Pubitemid 40136452)
40. Reddi A. H., Bone morphogenetic proteins: from basic science to clinical applications. Journal of Bone and Joint Surgery A 2001 83 supplement 1, part 1 S1 S6 2-s2.0-0002071012
41. Menendez M. I., Clark D. J., Carlton M., Flanigan D. C., Jia G., Sammet S., Weisbrode S. E., Knopp M. V., Bertone A. L., Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis and Cartilage 2011 19 8 1066 1075 2-s2.0-79960323461 10.1016/j.joca.2011.05.007
42. Christiansen J. H., Coles E. G., Wilkinson D. G., Molecular control of neural crest formation, migration and differentiation. Current Opinion in Cell Biology 2000 12 6 719 724 2-s2.0-0033709933 10.1016/S0955-0674(00)00158-7
43. Haid R. W. Jr., Branch C. L. Jr., Alexander J. T., Burkus J. K., Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine Journal 2004 4 5 527 538 2-s2.0-11144250305 10.1016/j.spinee.2004.03.025 (Pubitemid 40029169)
44. Haidar Z. S., Hamdy R. C., Tabrizian M., Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnology Letters 2009 31 12 1817 1824 2-s2.0-73949119177 10.1007/s10529-009-0099-x
45. Kempen D. H. R., Lu L., Heijink A., Hefferan T. E., Creemers L. B., Maran A., Yaszemski M. J., Dhert W. J. A., Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009 30 14 2816 2825 2-s2.0-61549132911 10.1016/j.biomaterials.2009.01.031
46. Boerckel J. D., Kolambkar Y. M., Dupont K. M., Uhrig B. A., Phelps E. A., Stevens H. Y., García A. J., Guldberg R. E., Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 2011 32 22 5241 5251 2-s2.0-79956095821 10.1016/j.biomaterials.2011.03.063
47. Li Q., Hou T., Zhao J., Xu J., Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells. Tissue Engineering A 2011 17 13-14 1777 1785 2-s2.0-79959555695 10.1089/ten.tea.2010.0616
48. Lochmann A., Nitzsche H., von Einem S., Schwarz E., Mäder K., The influence of covalently linked and free polyethylene glycol on the structural and release properties of rhBMP-2 loaded microspheres. Journal of Controlled Release 2010 147 1 92 100 2-s2.0-77954870985 10.1016/j.jconrel.2010.06.021
49. Patterson J., Siew R., Herring S. W., Lin A. S. P., Guldberg R., Stayton P. S., Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials 2010 31 26 6772 6781 2-s2.0-77954383096 10.1016/j.biomaterials.2010.05.047
50. Bock N., Woodruff M. A., Hutmacher D. W., Dargaville T. R., Electrospraying, a reproducible method for production of polymeric microspheres for biomedical applications. Polymers 2011 3 1 131 149 2-s2.0-79851501929 10.3390/polym3010131
51. Sukarto A., Amsden B. G., Low melting point amphiphilic microspheres for delivery of bone morphogenetic protein-6 and transforming growth factor- β 3 in a hydrogel matrix. Journal of Controlled Release 2012 158 1 53 62 2-s2.0-84857912638 10.1016/j.jconrel.2011.10.015
52. Solorio L., Zwolinski C., Lund A. W., Farrell M. J., Stegemann J. P., Gelatin microspheres crosslinked with genipin for local delivery of growth factors. Journal of Tissue Engineering and Regenerative Medicine 2010 4 7 514 523 2-s2.0-79251593973
53. Kempen D. H. R., Lu L., Hefferan T. E., Creemers L. B., Maran A., Classic K. L., Dhert W. J. A., Yaszemski M. J., Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008 29 22 3245 3252 2-s2.0-43749120033 10.1016/j.biomaterials. 2008.04.031
54. Chen S., Osaka A., Ikoma T., Morita H., Li J., Takeguchi M., Hanagata N., Fabrication, microstructure, and BMP-2 delivery of novel biodegradable and biocompatible silicate-collagen hybrid fibril sheets. Journal of Materials Chemistry 2011 21 29 10942 10948 2-s2.0-79960361008 10.1039/c1jm10829h
55. Martínez-Sanz E., Ossipov D. A., Hilborn J., Larsson S., Jonsson K. B., Varghese O. P., Bone reservoir: injectable hyaluronic acid hydrogel for minimal invasive bone augmentation. Journal of Controlled Release 2011 152 2 232 240 2-s2.0-79958276125 10.1016/j.jconrel.2011.02.003
56. Jiang T., Khan Y., Nair L. S., Abdel-Fattah W. I., Laurencin C. T., Functionalization of chitosan/poly(lactic acid-glycolic acid) sintered microsphere scaffolds via surface heparinization for bone tissue engineering. Journal of Biomedical Materials Research A 2010 93 3 1193 1208 2-s2.0-77950648427 10.1002/jbm.a.32615
57. Dawes G. J., Fratila-Apachitei L. E., Necula B. S., Apachitei I., van Leeuwen J. P., Duszczyk J., Eijken M., Effects of dexamethasone loaded plga microspheres on human fetal osteoblasts. Journal of Biomaterials Applications 2012 27 4 477 483
58. Bessa P. C., Balmayor E. R., Azevedo H. S., Nürnberger S., Casal M., Van Griensven M., Reis R. L., Redl H., Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. Journal of Tissue Engineering and Regenerative Medicine 2010 4 5 349 355 2-s2.0-77954264977 10.1002/term.245
59. Johnson M. R., Lee H. J., Bellamkonda R. V., Guldberg R. E., Sustained release of BMP-2 in a lipid-based microtube vehicle. Acta Biomaterialia 2009 5 1 23 28 2-s2.0-56349115299 10.1016/j.actbio.2008.09.001
60. Filion T. M., Kutikov A., Song J., Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds. Bioorganic and Medicinal Chemistry Letters 2011 21 17 5067 5070 2-s2.0-79955138575 10.1016/j.bmcl.2011. 04.032
61. Kirby G. T. S., White L. J., Rahman C. V., Cox H. C., Qutachi O., Rose F. R. A. J., Hutmacher D. W., Shakesheff K. M., Woodruff M. A., PLGA-based microparticles for the sustained release of BMP-2. Polymers 2011 3 1 571 586 10.3390/polym3010571
62. Schmitz J. P., Hollinger J. O., The critical size defect as an experimental model for craniomandibulofacial nonunions. Clinical Orthopaedics and Related Research 1986 205 205 299 308 2-s2.0-0022516213 (Pubitemid 16011282)
63. Ji Y., Xu G. P., Zhang Z. P., Xia J. J., Yan J. L., Pan S. H., BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Annals of Biomedical Engineering 2010 38 3 632 639 2-s2.0-77952009950 10.1007/s10439-009-9888-6
64. Hulsart-Billström G., Hu Q., Bergman K., Jonsson K. B., Åberg J., Tang R., Larsson S., Hilborn J., Calcium phosphates compounds in conjunction with hydrogel as carrier for BMP-2: a study on ectopic bone formation in rats. Acta Biomaterialia 2011 7 8 3042 3049 2-s2.0-79959825584 10.1016/j.actbio.2011. 04.021
65. Larsen M., Willems W. F., Pelzer M., Friedrich P. F., Yaszemski M. J., Bishop A. T., Augmentation of surgical angiogenesis in vascularized bone allotransplants with host-derived A/V bundle implantation, fibroblast growth factor-2, and vascular endothelial growth factor administration. Journal of Orthopaedic Research 2010 28 8 1015 1021 2-s2.0-77954696812 10.1002/jor.21098
66. Rath S. N., Pryymachuk G., Bleiziffer O. A., Lam C. X. F., Arkudas A., Ho S. T. B., Beier J. P., Horch R. E., Hutmacher D. W., Kneser U., Hyaluronan-based heparin-incorporated hydrogels for generation of axially vascularized bioartificial bone tissues: invitro and invivo evaluation in a PLDLLA-TCP-PCL-composite system. Journal of Materials Science 2011 22 5 1279 1291 2-s2.0-79953065097 10.1007/s10856-011-4300-0
67. Willems W. F., Larsen M., Giusti G., Friedrich P. F., Bishop A. T., Revascularization and bone remodeling of frozen allografts stimulated by intramedullary sustained delivery of FGF-2 and VEGF. Journal of Orthopaedic Research 2011 29 9 1431 1436 2-s2.0-79960246561 10.1002/jor.21338
68. Schofer M. D., Roessler P. P., Schaefer J., Theisen C., Schlimme S., Heverhagen J. T., Voelker M., Dersch R., Agarwal S., Fuchs-Winkelmann S., Paletta J. R. J., Electrospun plla nanofiber scaffolds and their use in combination with bmp-2 for reconstruction of bone defects. PLoS One 2011 6 9 e25462 2-s2.0-80053245870 10.1371/journal.pone.0025462
69. Suzuki A., Terai H., Toyoda H., Namikawa T., Yokota Y., Tsunoda T., Takaoka K., A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: a potential treatment for infected bone defects. Journal of Orthopaedic Research 2006 24 3 327 332 2-s2.0-33645750961 10.1002/jor.20049 (Pubitemid 43772992)
70. Young S., Patel Z. S., Kretlow J. D., Murphy M. B., Mountziaris P. M., Baggett L. S., Ueda H., Tabata Y., Jansen J. A., Wong M., Mikos A. G., Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Engineering A 2009 15 9 2347 2362 2-s2.0-69249088910 10.1089/ten.tea.2008.0510
71. Wu Z. X., Liu D., Wan S. Y., Cui G., Zhang Y., Lei W., Sustained-release rhBMP-2 increased bone mass and bone strength in an ovine model of postmenopausal osteoporosis. Journal of Orthopaedic Science 2011 16 1 99 104 2-s2.0-79953297461 10.1007/s00776-010-0019-x
72. Li M., Liu X., Liu X., Ge B., Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: a pilot study. Clinical Orthopaedics and Related Research 2010 468 7 1978 1985 2-s2.0-77954026484 10.1007/s11999-010-1321-9
73. Kolambkar Y. M., Boerckel J. D., Dupont K. M., Bajin M., Huebsch N., Mooney D. J., Hutmacher D. W., Guldberg R. E., Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone 2011 49 3 485 492 2-s2.0-79960581511 10.1016/j.bone.2011.05.010
74. Kirker-Head C., Karageorgiou V., Hofmann S., Fajardo R., Betz O., Merkle H. P., Hilbe M., von Rechenberg B., McCool J., Abrahamsen L., Nazarian A., Cory E., Curtis M., Kaplan D., Meinel L., BMP-silk composite matrices heal critically sized femoral defects. Bone 2007 41 2 247 255 2-s2.0-34347234496 10.1016/j.bone.2007.04.186 (Pubitemid 47001819)
75. Brown K. V., Li B., Guda T., Perrien D. S., Guelcher S. A., Wenke J. C., Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Engineering A 2011 17 13-14 1735 1746 2-s2.0-79959555090 10.1089/ten.tea.2010.0446
76. Jeon O., Song S. J., Kang S. W., Putnam A. J., Kim B. S., Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold. Biomaterials 2007 28 17 2763 2771 2-s2.0-33947178806 10.1016/j.biomaterials.2007.02.023 (Pubitemid 46413347)
77. Jeon O., Rhie J. W., Kwon I. K., Kim J. H., Kim B. S., Lee S. H., In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically. Tissue Engineering A 2008 14 8 1285 1294 2-s2.0-48749124949 10.1089/ten.tea.2007.0253
78. Henslee A. M., Spicer P. P., Yoon D. M., Nair M. B., Meretoja V. V., Witherel K. E., Jansen J. A., Mikos A. G., Kasper F. K., Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomaterialia 2011 7 10 3627 3637 2-s2.0-79960532574 10.1016/j.actbio.2011.06.043
79. Luca L., Rougemont A. L., Walpoth B. H., Boure L., Tami A., Anderson J. M., Jordan O., Gurny R., Injectable rhBMP-2-loaded chitosan hydrogel composite: Osteoinduction at ectopic site and in segmental long bone defect. Journal of Biomedical Materials Research A 2011 96 1 66 74 2-s2.0-78649552759 10.1002/jbm.a.32957
80. Reichert J. C., Epari D. R., Wullschleger M. E., Saifzadeh S., Steck R., Lienau J., Sommerville S., Dickinson I. C., Schütz M. A., Duda G. N., Hutmacher D. W., Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Engineering B 2010 16 1 93 104 2-s2.0-76749129433 10.1089/ten.teb.2009.0455
81. Whitaker M. J., Quirk R. A., Howdle S. M., Shakesheff K. M., Growth factor release from tissue engineering scaffolds. Journal of Pharmacy and Pharmacology 2001 53 11 1427 1437 2-s2.0-0035165289 10.1211/0022357011777963 (Pubitemid 33064532)
82. Sakiyama-Elbert S. E., Hubbell J. A., Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. Journal of Controlled Release 2000 69 1 149 158 2-s2.0-0034601868 10.1016/S0168-3659(00) 00296-0
83. Kang S. W., Kim J. S., Park K. S., Cha B. H., Shim J. H., Kim J. Y., Cho D. W., Rhie J. W., Lee S. H., Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. Bone 2011 48 2 298 306 2-s2.0-78650976404 10.1016/j.bone.2010.09.029
84. Sokolsky-Papkov M., Agashi K., Olaye A., Shakesheff K., Domb A. J., Polymer carriers for drug delivery in tissue engineering. Advanced Drug Delivery Reviews 2007 59 4-5 187 206 2-s2.0-34250007423 10.1016/j.addr.2007.04.001 (Pubitemid 46887622)
85. Chaisri W., Ghassemi A. H., Hennink W. E., Okonogi S., Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Colloids and Surfaces B 2011 84 2 508 514 2-s2.0-79952814519 10.1016/j.colsurfb.2011.02.006
86. Saito E., Liao E. E., Hu W. W., Krebsbach P. H., Hollister S. J., Effects of designed PLLA and 50:50 PLGA scaffold architectures on bone formation in vivo. Journal of Tissue Engineering and Regenerative Medicine. In press 10.1002/term.497
87. Kanczler J. M., Barry J., Ginty P., Howdle S. M., Shakesheff K. M., Oreffo R. O. C., Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(dl-lactic acid) scaffolds induce angiogenesis in vitro. Biochemical and Biophysical Research Communications 2007 352 1 135 141 2-s2.0-33751417621 10.1016/j.bbrc.2006.10.187 (Pubitemid 44821105)
88. Murphy W. L., Peters M. C., Kohn D. H., Mooney D. J., Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co- glycolide) scaffolds for tissue engineering. Biomaterials 2000 21 24 2521 2527 2-s2.0-0034672889
89. Yang X. B., Whitaker M. J., Sebald W., Clarke N., Howdle S. M., Shakesheff K. M., Oreffo R. O. C., Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Engineering 2004 10 7-8 1037 1045 2-s2.0-4544374940 10.1089/ten.2004.10.1037 (Pubitemid 39223783)
90. Howdle S. M., Watson M. S., Whitaker M. J., Popov V. K., Davies M. C., Mandel F. S., Wang J. D., Shakesheff K. M., Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chemical Communications 2001 1 109 110 2-s2.0-0035819362 (Pubitemid 32094839)
91. Kanczler J. M., Ginty P. J., White L., Clarke N. M. P., Howdle S. M., Shakesheff K. M., Oreffo R. O. C., The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 2010 31 6 1242 1250 2-s2.0-72449179318 10.1016/j.biomaterials.2009.10.059
92. Macdonald M. L., Samuel R. E., Shah N. J., Padera R. F., Beben Y. M., Hammond P. T., Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011 32 5 1446 1453 2-s2.0-78649724173 10.1016/j.biomaterials.2010.10.052
93. Sanders E. H., Kloefkorn R., Bowlin G. L., Simpson D. G., Wnek G. E., Two-phase electrospinning from a single electrified jet: microencapsulation of aqueous reservoirs in poly(ethylene-co-vinyl acetate) fibers. Macromolecules 2003 36 11 3803 3805 2-s2.0-0038408492 10.1021/ma021771l
94. Jiang H., Hu Y., Li Y., Zhao P., Zhu K., Chen W., A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. Journal of Controlled Release 2005 108 2-3 237 243 2-s2.0-27744591467 10.1016/j.jconrel.2005.08.006 (Pubitemid 41608657)
95. Liao I. C., Chew S. Y., Leong K. W., Aligned core-shell nanofibers delivering bioactive proteins. Nanomedicine 2006 1 4 465 471 2-s2.0-34548628477 10.2217/17435889.1.4.465
96. Hadjiargyrou M., Chiu J. B., Enhanced composite electrospun nanofiber scaffolds for use in drug delivery. Expert Opinion on Drug Delivery 2008 5 10 1093 1106 2-s2.0-55049127968 10.1517/17425247.5.10.1093
97. Nie H., Beng W. S., Fu Y. C., Wang C. H., Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnology and Bioengineering 2008 99 1 223 234 2-s2.0-37549031767 10.1002/bit.21517
98. Li C., Vepari C., Jin H. J., Kim H. J., Kaplan D. L., Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006 27 16 3115 3124 2-s2.0-32644479707 10.1016/j.biomaterials.2006.01.022 (Pubitemid 43247585)
99. Fu Y. C., Nie H., Ho M. L., Wang C. K., Wang C. H., Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnology and Bioengineering 2008 99 4 996 1006 2-s2.0-39549119382 10.1002/bit.21648 (Pubitemid 351316641)
100. Choi J. S., Leong K. W., Yoo H. S., In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 2008 29 5 587 596 2-s2.0-36048959183 10.1016/j.biomaterials.2007.10.012 (Pubitemid 350100803)
101. Chew S. Y., Wen J., Yim E. K. F., Leong K. W., Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 2005 6 4 2017 2024 2-s2.0-22944443610 10.1021/bm0501149 (Pubitemid 41052194)
102. Paletta J. R. J., Erffmeier K., Theisen C., Hussain D., Wendorff J. H., Greiner A., Fuchs-Winkelmann S., Schofer M. D., Influence of poly-(L-lactic acid) nanofiber functionalization on maximum load, Young's modulus, and strain of nanofiber scaffolds before and after cultivation of osteoblasts: an in vitro study. TheScientificWorldJournal 2009 9 1382 1393 2-s2.0-77449093838 10.1100/tsw.2009.149
103. Schofer M. D., Fuchs-Winkelmann S., Gräbedünkel C., Wack C., Dersch R., Rudisile M., Wendorff J. H., Greiner A., Paletta J. R. J., Boudriot U., Influence of poly(L-lactic acid) nanofibers and BMP-2-containing poly(L-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. TheScientificWorldJournal 2008 8 1269 1279 2-s2.0-58449111216 10.1100/tsw.2008.163
104. Chen L., Liu L., Li C., Tan Y., Zhang G., A new growth factor controlled drug release system to promote healing of bone fractures: nanospheres of recombinant human bone morphogenetic-2 and polylactic acid. Journal of Nanoscience and Nanotechnology 2011 11 4 3107 3114 2-s2.0-80051917192 10.1166/jnn.2011.3820
105. Ungaro F., Biondi M., d'Angelo I., Indolfi L., Quaglia F., Netti P. A., La Rotonda M. I., Microsphere-integrated collagen scaffolds for tissue engineering: effect of microsphere formulation and scaffold properties on protein release kinetics. Journal of Controlled Release 2006 113 2 128 136 2-s2.0-33745265629 10.1016/j.jconrel.2006.04.011 (Pubitemid 43928147)
106. Schnieders J., Gbureck U., Vorndran E., Schossig M., Kissel T., The effect of porosity on drug release kinetics from vancomycin microsphere/calcium phosphate cement composites. Journal of Biomedical Materials Research B 2011 99 2 391 398 10.1002/jbm.b.31910
107. dos Santos D. F., Bitencourt C. S., Gelfuso G. M., Pereira P. A. T., de Souza P. R. M., Sorgi C. A., Nicolete R., Faccioli L. H., Biodegradable microspheres containing leukotriene B4 and cell-free antigens from Histoplasma capsulatum activate murine bone marrow-derived macrophages. European Journal of Pharmaceutical Sciences 44 5 580 588
108. de Laporte L., des Rieux A., Tuinstra H. M., Zelivyanskaya M. L., De Clerck N. M., Postnov A. A., Préat V., Shea L. D., Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. Journal of Biomedical Materials Research A 2011 98 3 372 382 2-s2.0-79960358602 10.1002/jbm.a.33112
109. Shen H., Hu X., Yang F., Bei J., Wang S., An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomaterialia 2010 6 2 455 465 2-s2.0-72049090642 10.1016/j.actbio.2009. 07.016
110. Lee W. L., Loei C., Widjaja E., Loo S. C. J., Altering the drug release profiles of double-layered ternary-phase microparticles. Journal of Controlled Release 2011 151 3 229 238 2-s2.0-79957474023 10.1016/j.jconrel.2011.02.012
111. Jiang T., Petersen R. R., Call G., Ofek G., Gao J., Yao J. Q., Development of chondroitin sulfate encapsulated PLGA microsphere delivery systems with controllable multiple burst releases for treating osteoarthritis. Journal of Biomedical Materials Research B 2011 97 2 355 363 2-s2.0-79953801777 10.1002/jbm.b.31822
112. Wischke C., Schwendeman S. P., Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. International Journal of Pharmaceutics 2008 364 2 298 327 2-s2.0-55649104973 10.1016/j.ijpharm.2008.04.042
113. Fu K., Xu Q., Czernuszka J., McKenna C. E., Ebetino F. H., Russell R. G. G., Triffitt J. T., Xia Z., Prolonged osteogenesis from human mesenchymal stem cells implanted in immunodeficient mice by using coralline hydroxyapatite incorporating rhBMP2 microspheres. Journal of Biomedical Materials Research A 2010 92 4 1256 1264 2-s2.0-77349126917 10.1002/jbm.a.32453
114. Kempen D. H. R., Yaszemski M. J., Heijink A., Hefferan T. E., Creemers L. B., Britson J., Maran A., Classic K. L., Dhert W. J. A., Lu L., Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. Journal of Controlled Release 2009 134 3 169 176 2-s2.0-61349098782 10.1016/j.jconrel.2008.11.023
115. Reyes R., de la Riva B., Delgado A., Hernández A., Sánchez E., Évora C., Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect. Injury 2012 43 3 334 342 2-s2.0-84857361387 10.1016/j.injury.2011.10.008
116. Rui J., Dadsetan M., Runge M. B., Spinner R. J., Yaszemski M. J., Windebank A. J., Wang H., Controlled release of vascular endothelial growth factor using poly-lactic-co-glycolic acid microspheres: in vitro characterization and application in polycaprolactone fumarate nerve conduits. Acta Biomaterialia 2012 8 2 511 518 2-s2.0-84855469882 10.1016/j.actbio.2011.10. 001
117. King W. J., Toepke M. W., Murphy W. L., Facile formation of dynamic hydrogel microspheres for triggered growth factor delivery. Acta Biomaterialia 2011 7 3 975 985 2-s2.0-79251620613 10.1016/j.actbio.2010.10.026
118. Sun Q., Silva E. A., Wang A., Fritton J. C., Mooney D. J., Schaffler M. B., Grossman P. M., Rajagopalan S., Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharmaceutical Research 2010 27 2 264 271 2-s2.0-77949270271 10.1007/s11095-009-0014-0
119. Mooney D. J., Kaufmann P. M., Sano K., Schwendeman S. P., Majahod K., Schloo B., Vacanti J. P., Langer R., Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes. Biotechnology and
120. Dormer N. H., Busaidy K., Berkland C. J., Detamore M. S., Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients. Journal of Oral and Maxillofacial Surgery 2011 69 6 e50 e57 2-s2.0-79956372005 10.1016/j.joms.2010.12.049
121. Xu X., Jha A. K., Duncan R. L., Jia X., Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomaterialia 2011 7 8 3050 3059 2-s2.0-79959831619 10.1016/j.actbio.2011.04.018
122. Hernández A., Sánchez E., Soriano I., Reyes R., Delgado A., Évora C., Material-related effects of BMP-2 delivery systems on bone regeneration. Acta Biomaterialia 2012 8 2 781 791
123. Freitas S., Merkle H. P., Gander B., Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of Controlled Release 2005 102 2 313 332 2-s2.0-11844259383 10.1016/j.jconrel.2004.10.015
124. Li M., Rouaud O., Poncelet D., Microencapsulation by solvent evaporation: state of the art for process engineering approaches. International Journal of Pharmaceutics 2008 363 1-2 26 39 2-s2.0-51649129933 10.1016/j.ijpharm.2008.07. 018
125. Park J. S., Lee J. H., Shin H. S., Lee T. W., Kim M. S., Khang G., Rhee J. M., Lee H. K., Lee H. B., Biodegradable polymer microspheres for controlled drug release. Tissue Engineering and Regenerative Medicine 2007 4 3 347 359
126. Freiberg S., Zhu X. X., Polymer microspheres for controlled drug release. International Journal of Pharmaceutics 2004 282 1-2 1 18 2-s2.0-4444246813 10.1016/j.ijpharm.2004.04.013 (Pubitemid 39178480)
127. Cohen S., Yoshioka T., Lucarelli M., Hwang L. H., Langer R., Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharmaceutical Research 1991 8 6 713 720 2-s2.0-0025731293
128. Bilati U., Allémann E., Doelker E., Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. European Journal of Pharmaceutics and Biopharmaceutics 2005 59 3 375 388 2-s2.0-14844317382 10.1016/j.ejpb.2004.10.006 (Pubitemid 40342512)
129. Johnson P. J., Skornia S. L., Stabenfeldt S. E., Willits R. K., Maintaining bioactivity of NGF for controlled release from PLGA using PEG. Journal of Biomedical Materials Research A 2008 86 2 420 427 2-s2.0-47049098671 10.1002/jbm.a.31635 (Pubitemid 351969640)
130. Crotts G., Park T. G., Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. Journal of Microencapsulation 1998 15 6 699 713 2-s2.0-0031752709 (Pubitemid 28490941)
131. Bertram J. P., Rauch M. F., Chang K., Lavik E. B., Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF. Pharmaceutical Research 2010 27 1 82 91 2-s2.0-72949094427 10.1007/s11095-009-0009-x
132. Morita T., Sakamura Y., Horikiri Y., Suzuki T., Yoshino H., Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. Journal of Controlled Release 2000 69 3 435 444 2-s2.0-0034602599 10.1016/S0168-3659(00) 00326-6
133. Suciati T., Howard D., Barry J., Everitt N. M., Shakesheff K. M., Rose F. R., Zonal release of proteins within tissue engineering scaffolds. Journal of Materials Science 2006 17 11 1049 1056 2-s2.0-33751545271 10.1007/s10856-006- 0443-9 (Pubitemid 44835991)
134. Cao Z., Chen X., Yao J., Huang L., Shao Z., The preparation of regenerated silk fibroin microspheres. Soft Matter 2007 3 7 910 915 2-s2.0-34250620380 10.1039/b703139d (Pubitemid 46946215)
135. Ye M., Kim S., Park K., Issues in long-term protein delivery using biodegradable microparticles. Journal of Controlled Release 2010 146 2 241 260 2-s2.0-77955418929 10.1016/j.jconrel.2010.05.011
136. Valo H., Peltonen L., Vehviläinen S., Karjalainen M., Kostiainen R., Laaksonen T., Hirvonen J., Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles. Small 2009 5 15 1791 1798 2-s2.0-69049088947 10.1002/smll.200801907
137. Almería B., Fahmy T. M., Gomez A., A multiplexed electrospray process for single-step synthesis of stabilized polymer particles for drug delivery. Journal of Controlled Release 2011 154 2 203 210 2-s2.0-79958795280 10.1016/j.jconrel.2011.05.018
138. Wang F., Li Z. Q., Tamama K., Sen C. K., Guan J. J., Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules 2009 10 9 2609 2618 2-s2.0-70349188341 10.1021/bm900541u
139. Ekaputra A. K., Prestwich G. D., Cool S. M., Hutmacher D. W., The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (e{open}-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials 2011 32 32 8108 8117 2-s2.0-79960656077 10.1016/j.biomaterials. 2011.07.022
140. Wei G. B., Jin Q. M., Giannobile W. V., Ma P. X., The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007 28 12 2087 2096 2-s2.0-33846657400 10.1016/j.biomaterials. 2006.12.028 (Pubitemid 46198923)
141. Li B., Yoshii T., Hafeman A. E., Nyman J. S., Wenke J. C., Guelcher S. A., The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials 2009 30 35 6768 6779 2-s2.0-70349871404 10.1016/j.biomaterials.2009.08.038
142. Cho T. J., Gerstenfeld L. C., Einhorn T. A., Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. Journal of Bone and Mineral Research 2002 17 3 513 520 2-s2.0-0036181393 (Pubitemid 34171766)
143. Kempen D. H. R., Kruyt M. C., Lu L., Wilson C. E., Florschutz A. V., Creemers L. B., Yaszemski M. J., Dhert W. J. A., Effect of autologous bone marrow stromal cell seeding and bone morphogenetic protein-2 delivery on ectopic bone formation in a microsphere/poly(propylene fumarate) composite. Tissue Engineering A 2009 15 3 587 594 2-s2.0-64549129642 10.1089/ten.tea.2007.0376
144. Woo B. H., Fink B. F., Page R., Schrier J. A., Jo Y. W., Jiang G., DeLuca M., Vasconez H. C., DeLuca P. P., Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharmaceutical Research 2001 18 12 1747 1753 2-s2.0-0035668346 10.1023/A:1013382832091 (Pubitemid 34020432)
145. Nguyen M. K., Lee D. S., Injectable biodegradable hydrogels. Macromolecular Bioscience 2010 10 6 563 579 2-s2.0-77953626607 10.1002/mabi.200900402
146. Zhu J., Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010 31 17 4639 4656 2-s2.0-77951089569 10.1016/j.biomaterials.2010.02.044
147. Zhang W., Wang X., Wang S., Zhao J., Xu L., Zhu C., Zeng D., Chen J., Zhang Z., Kaplan D. L., Jiang X., The use of injectable sonication-induced silk hydrogel for VEGF165 and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 2011 32 35 9415 9424 10.1016/j.biomaterials.2011.08.047
148. Luca L., Rougemont A. L., Walpoth B. H., Gurny R., Jordan O., The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. Journal of Controlled Release 2010 147 1 38 44 2-s2.0-77954410626 10.1016/j.jconrel.2010. 06.011
149. Wen B., Karl M., Pendrys D., Shafer D., Freilich M., Kuhn L., An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model. Journal of Biomedical Materials Research B 2011 97 2 315 326 2-s2.0-79953802041 10.1002/jbm.b.31817
150. Hayashi C., Hasegawa U., Saita Y., Hemmi H., Hayata T., Nakashima K., Ezura Y., Amagasa T., Akiyoshi K., Noda M., Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. Journal of Cellular Physiology 2009 220 1 1 7 2-s2.0-65549157815 10.1002/jcp.21760
151. Lutolf M. P., Lauer-Fields J. L., Schmoekel H. G., Metters A. T., Weber F. E., Fields G. B., Hubbell J. A., Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proceedings of the National Academy of Sciences of the United States of America 2003 100 9 5413 5418 2-s2.0-0037965624 10.1073/pnas.0737381100 (Pubitemid 36542719)
152. Liu S. Q., Tian Q., Wang L., Hedrick J. L., Po Hui J. H., Yan Yang Y., Ee P. L. R., Injectable biodegradable polyethylene glycol/ RGD peptide hybrid hydrogels for in vitro chondrogenesis of human mesenchymal stern cellsa. Macromolecular Rapid Communications 2010 31 13 1148 1154 2-s2.0-77954188908 10.1002/marc.200900818
153. Zieris A., Chwalek K., Prokoph S., Levental K. R., Welzel P. B., Freudenberg U., Werner C., Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. Journal of Controlled Release 2011 156 1 28 36 2-s2.0-79961003059 10.1016/j.jconrel.2011.06.042
154. Hänseler P., Jung U. W., Jung R. E., Choi K. H., Cho K. S., Hämmerle C. H. F., Weber F. E., Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2. Acta Biomaterialia 2012 8 1 116 123
155. Hao X., Silva E. A., Månsson-Broberg A., Grinnemo K. H., Siddiqui A. J., Dellgren G., Wärdell E., Brodin L. Å., Mooney D. J., Sylvén C., Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovascular Research 2007 75 1 178 185 2-s2.0-34249933136 10.1016/j.cardiores.2007.03.028 (Pubitemid 46876668)
156. Simmons C. A., Alsberg E., Hsiong S., Kim W. J., Mooney D. J., Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004 35 2 562 569 2-s2.0-3142703230 10.1016/j.bone.2004.02.027 (Pubitemid 38953205)
157. Schmidmaier G., Wildemann B., Gäbelein T., Heeger J., Kandziora F., Haas N. P., Raschke M., Synergistic effect of IGF-I and TGF- β 1 on fracture healing in rats: single versus combined application of IGF-I and TGF- β 1. Acta Orthopaedica Scandinavica 2003 74 5 604 610 2-s2.0-0142209286 10.1080/00016470310018036 (Pubitemid 37310970)
158. Basmanav F. B., Kose G. T., Hasirci V., Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008 29 31 4195 4204 2-s2.0-49349102874 10.1016/j.biomaterials.2008.07.017
159. Jaklenec A., Hinckfuss A., Bilgen B., Ciombor D. M., Aaron R., Mathiowitz E., Sequential release of bioactive IGF-I and TGF- β 1 from PLGA microsphere-based scaffolds. Biomaterials 2008 29 10 1518 1525 2-s2.0-38349108489 10.1016/j.biomaterials.2007.12.004
160. Kaigler D., Krebsbach P. H., West E. R., Horger K., Huang Y. C., Mooney D. J., Endothelial cell modulation of bone marrow stromal cell osteogenic potential. The FASEB Journal 2005 19 6 665 667 2-s2.0-16344377895 10.1096/fj.04-2529fje (Pubitemid 40471279)
161. Kanczler J. M., Ginty P. J., Barry J. J. A., Clarke N. M. P., Howdle S. M., Shakesheff K. M., Oreffo R. O. C., The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 2008 29 12 1892 1900 2-s2.0-39749193991 10.1016/j.biomaterials.2007.12.031
162. Cleland J. L., Duenas E. T., Park A., Daugherty A., Kahn J., Kowalski J., Cuthbertson A., Development of poly-(D,L-lactide-coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. Journal of Controlled Release 2001 72 1-3 13 24 2-s2.0-0035858370 10.1016/S0168-3659(01)00258-9 (Pubitemid 32522340)
163. King T. W., Patrick C. W., Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. Journal of Biomedical Materials Research 2000 51 3 383 390 (Pubitemid 30452141)
164. Patel Z. S., Young S., Tabata Y., Jansen J. A., Wong M. E. K., Mikos A. G., Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008 43 5 931 940 2-s2.0-51449094036 10.1016/j.bone.2008.06.019
165. Richardson T. P., Peters M. C., Ennett A. B., Mooney D. J., Polymeric system for dual growth factor delivery. Nature Biotechnology 2001 19 11 1029 1034 2-s2.0-0034760458 10.1038/nbt1101-1029 (Pubitemid 33041886)